Cancelling mRNA studies is the highest irresponsibility
By Editors,
Nature
| 08. 15. 2025
The rest of the world is not following the US government’s dangerous path, and will stick with the technology that helped the world out of the COVID-19 pandemic.
A technology that played a key part in saving millions of lives during the COVID-19 pandemic1 should be feted to the skies. Instead, US health secretary Robert F. Kennedy Jr announced last week that the US federal government is terminating 22 grants worth nearly US$500 million for projects researching messenger RNA (mRNA) vaccines.
This is the technology that, in his first term (2017–21), US President Donald Trump included in Operation Warp Speed: the federal government’s $18-billion programme to procure COVID-19 vaccines for US populations in record time2. It is also the technology that is showing potential for treating cancers3, autoimmune diseases and inherited conditions such as sickle cell disease. But now, in a statement accompanying the grant cancellations, Kennedy stated that “these vaccines fail to protect effectively against upper respiratory infections like COVID and flu”. And in an article for The Washington Post, Jay Bhattacharya, director of the US National Institutes of Health, wrote that mRNA technology “failed to earn the public’s trust”, which fuelled vaccine hesitancy.
Shock and disbelief does not even begin...
Related Articles
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia
As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...
By Johana Bhuiyan, The Guardian | 09.23.2025
In March 2021, a 25-year-old US citizen was traveling through Chicago’s Midway airport when they were stopped by US border patrol agents. Though charged with no crime, the 25-year-old was subjected to a cheek swab to collect their DNA, which...
